AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have been given a consensus recommendation of “Moderate Buy” by the six research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $11.67.

Several research analysts have commented on the company. Truist Financial cut their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, November 15th. Robert W. Baird cut their target price on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. Canaccord Genuity Group decreased their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. UBS Group reduced their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Finally, Royal Bank of Canada lowered their price target on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a report on Tuesday, November 19th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Canada Pension Plan Investment Board acquired a new position in AdaptHealth during the second quarter worth $58,000. Quarry LP grew its stake in shares of AdaptHealth by 4,596.9% during the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after purchasing an additional 5,838 shares during the period. Innealta Capital LLC purchased a new position in shares of AdaptHealth in the 2nd quarter valued at about $101,000. Quest Partners LLC lifted its stake in shares of AdaptHealth by 11,522.7% in the second quarter. Quest Partners LLC now owns 10,228 shares of the company’s stock valued at $102,000 after purchasing an additional 10,140 shares during the period. Finally, CIBC Asset Management Inc purchased a new stake in AdaptHealth during the third quarter worth about $122,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Stock Down 1.2 %

AHCO stock opened at $10.05 on Thursday. The company’s 50 day moving average is $10.09 and its two-hundred day moving average is $10.44. AdaptHealth has a twelve month low of $6.46 and a twelve month high of $11.90. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The stock has a market cap of $1.35 billion, a P/E ratio of -6.09, a PEG ratio of 1.36 and a beta of 1.10.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). The company had revenue of $805.90 million during the quarter, compared to analysts’ expectations of $809.32 million. AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. AdaptHealth’s revenue was up .2% on a year-over-year basis. During the same period last year, the firm earned $0.19 earnings per share. Research analysts expect that AdaptHealth will post 0.88 earnings per share for the current fiscal year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.